Document Detail


Trials in kidney disease--time to EVOLVE.
MedLine Citation:
PMID:  23121375     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Vlado Perkovic; Bruce Neal
Related Documents :
23767335 - The experience and self-management of fatigue in patients on hemodialysis.
23490395 - Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old...
21276525 - Pathology-designed custom molded foot orthoses.
23795275 - Lenalidomide in combination with dexamethasone in elderly patients with advanced, relap...
7633345 - Informed consent: an essential element of safe anesthesia practice.
3886065 - Evaluation of obstructive uropathy in children. 99mtc-dtpa renography studies under con...
Publication Detail:
Type:  Comment; Editorial     Date:  2012-11-03
Journal Detail:
Title:  The New England journal of medicine     Volume:  367     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-27     Completed Date:  2013-01-07     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2541-2     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiovascular Diseases / prevention & control*
Female
Humans
Hyperparathyroidism, Secondary / drug therapy*
Kidney Failure, Chronic / drug therapy*
Male
Naphthalenes / therapeutic use*
Renal Dialysis*
Chemical
Reg. No./Substance:
0/Naphthalenes; UAZ6V7728S/cinacalcet
Comments/Corrections
Comment On:
N Engl J Med. 2012 Dec 27;367(26):2482-94   [PMID:  23121374 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
Next Document:  Aquaretic Treatment in Polycystic Kidney Disease.